ANEBULO PHARMACEUTICALS, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ANEBULO PHARMACEUTICALS, INC. stock issued during period, value, new issues for the quarter ending 2024-12-31 was $14.96M, a 2187.83% increase year-over-year.
- ANEBULO PHARMACEUTICALS, INC. stock issued during period, value, new issues for the quarter ending 2023-12-31 was $654.00K.
- ANEBULO PHARMACEUTICALS, INC. stock issued during period, value, new issues for the quarter ending 2022-09-30 was $6.40M.
- ANEBULO PHARMACEUTICALS, INC. stock issued during period, value, new issues for fiscal 2025 was $14.88M, a 2175.74% increase from fiscal 2024.
- ANEBULO PHARMACEUTICALS, INC. stock issued during period, value, new issues for fiscal 2024 was $654.00K, a 89.67% decline from fiscal 2023.
- ANEBULO PHARMACEUTICALS, INC. stock issued during period, value, new issues for fiscal 2023 was $6.33M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2025-06-30 | $14.88M 10-K · filed 2025-09-29 | |
| 2024-12-31 | $14.96M 10-Q · filed 2026-02-12 | |
| 2024-06-30 | $654.00K 10-K · filed 2025-09-29 | |
| 2023-12-31 | $654.00K 10-Q · filed 2025-05-13 | |
| 2023-06-30 | $6.33M 10-K · filed 2024-09-25 | |
| 2022-09-30 | $6.40M 10-Q · filed 2024-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |